Trial Profile
Effects of inhaled tiotropium bromide on severity of airflow obstruction during long-term treatment in patients with moderately severe COPD [chronic obstructive pulmonary disease]. Impact on severity and incidence of exacerbations
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Oct 2009
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 28 Mar 2007 New trial record.